Table 1.
Demographic and clinical characteristics of the study participants.
Table 2.
Percepta GSC performance.
Table 3.
Patients* with down-classified low- and intermediate-risk benign lesions who underwent additional invasive procedures.
Table 4.
Patients* with intermediate- and high-risk lesions that were up-classified by Percepta GSC and underwent additional procedures prior to malignant diagnosis.